Prescription Opioid Statistics

Prescription opioids affect millions — roughly 9.4 million U.S. adults have an opioid use disorder, and 8 to 12 percent of people prescribed them develop addiction. Tens of thousands die each year, yet effective treatment exists and reaches too few.

Jessica Miller is the Content Manager of Addiction HelpWritten by
Kent S. Hoffman, D.O. is a founder of Addiction HelpMedically reviewed by Kent S. Hoffman, D.O.
Last updated

Battling addiction & ready for help?

Find Treatment Now

Prescription Opioid Statistics, in Plain Numbers

Prescription painkillers are not a fringe problem. Millions of Americans misuse them, a meaningful minority become addicted, and the path that began with a pill bottle now feeds into the deadliest drug supply in the country’s history.

If you are reading this because your own use, or someone else’s, feels like it is sliding out of control, these numbers are not here to shame you. They are here to show you that this is common, it is understood, and it is treatable. Every figure is drawn from peer-reviewed research and national health data, not round-number guesses, and each one is sourced.

An opioid overdose can be reversed, if you act fast. Naloxone (Narcan) buys the minutes that save a life.
If you or someone you love is in crisis, call or text 988 any time to reach a trained counselor.

What to do:

  • Carry naloxone (Narcan). It reverses an opioid overdose within minutes. Give it and call 911, and keep it on hand if anyone you love uses. Find treatment that gets you onto medication.
  • Get into treatment. Medications like buprenorphine (Suboxone) and methadone ease withdrawal and cut the risk of dying, the easier way out instead of white-knuckling it alone.
  • Never use alone. Most opioid overdoses are survivable when someone is there to call for help and give naloxone in time.

Find treatment today →

AddictionHelp.com Fast Facts
  • 9.37 million US adults had an opioid use disorder in 2022: about 3.7% of all adults, and 8 to 12% of people who misuse opioids go on to develop addiction[1][2]
  • 53,774 Americans died of opioid overdose in 2024: roughly double the toll of twenty years earlier[1]
  • The medications that work cut the risk of dying by about half, yet only 25.1% of people receive them: methadone or buprenorphine is the way out, and the treatment gap is the crisis within the crisis[1]

How Many People Misuse Prescription Opioids

What ‘opioid use disorder’ meansIt is the clinical name for opioid addiction: the medical term you will see in research and at a treatment center. Using it does not change who a person is. It simply names a condition that doctors know how to treat.

The scale is large, and it sits on a spectrum that runs from occasional misuse to severe addiction.

In 2022, an estimated 9.37 million US adults, about 3.7% of the adult population, met the criteria for an opioid use disorder[1]. That category covers prescription painkillers like oxycodone and hydrocodone alongside heroin and fentanyl, because once the brain is hooked, the chemistry behaves the same regardless of where the drug came from. Worldwide, roughly 27 million people live with opioid addiction[3].

The Headline Number

9.37 million US adults had an opioid use disorder in 2022, about 3.7% of everyone over 18[1]. That is roughly one in every 27 adults, sitting in classrooms, offices, churches, and family dinners. The condition is far more common than the silence around it suggests.

Misuse does not always mean addiction, and that distinction matters. Taking a pill more often than prescribed, using someone else’s medication, or taking it to get high is misuse. Addiction is the smaller, more serious circle inside it, marked by craving and loss of control. Roughly 8 to 12% of people who misuse opioids go on to develop an opioid use disorder[2]. Most people prescribed opioids for pain never become addicted, but across a population that has filled tens of millions of prescriptions, the minority who do still number in the millions.

If you are somewhere on this spectrum, you are not an outlier and you are not beyond help. The line between heavy use and addiction is real, but crossing it does not make recovery less possible. It makes getting onto treatment more urgent.

Who Is Affected by Prescription Opioid Addiction

‘Co-occurring’ is not a character flawWhen research counts a second condition alongside addiction, it is describing things that show up together, not blame stacked on a person. Carrying more than one struggle is ordinary, and good care is built to hold all of it at once.

Opioid use disorder rarely shows up as a single, isolated problem, and the data describe what tends to travel alongside it.

Among people with an opioid use disorder, 59.5% also have another current substance use disorder, most often involving cocaine, alcohol, or cannabis[4]. Mental-health conditions are common too. Across the research, 36.1% have current depression, 29.1% have anxiety, 18.1% have PTSD, and 20.9% have ADHD[5]. Chronic pain is woven through the picture as well: about 45.3% of people receiving opioid-substitution treatment also live with chronic pain[6].

There is also a deeper pattern underneath who develops opioid problems in the first place. A systematic review of adverse childhood experiences found a dose-response link with opioid use behaviors, meaning the more childhood trauma a person carried, the higher the risk, a pattern that held across every study reviewed[7].

Who is affected Share of people with OUD Source
Another substance use disorder 59.5% [4]
Chronic pain (in OST) 45.3% [6]
Depression 36.1% [5]
Anxiety 29.1% [5]
ADHD 20.9% [5]
PTSD 18.1% [5]

For anyone weighing whether to ask for help, complexity is the norm, not a reason to be turned away. Good treatment expects the whole picture, the pain, the depression, the other substances, and treats the person rather than the opioid in isolation.

The Three Waves of the Opioid Epidemic

Today’s numbers did not appear all at once. The crisis built in three distinct waves, and understanding them explains how so many families who never expected this ended up inside it.

Wave One Was Prescription Painkillers

The first wave began in the late 1990s with prescription painkillers. After 1996, prescribing of drugs like OxyContin expanded sharply, driven in part by industry-funded research from the manufacturer that misrepresented how addictive these drugs were. Doctors wrote prescriptions in good faith for back pain, surgery, and injury. Most patients never developed a problem, but a meaningful minority did, and across tens of millions of prescriptions, that share became a public-health emergency.

Wave Two Was Heroin

The second wave followed as pills became harder and more expensive to get. Many people who were already dependent moved to heroin, which was cheaper and easier to find on the street. The pathway from the medicine cabinet to the needle is well documented, and it caught people who had started with nothing more than a legitimate prescription.

Wave Three Is Fentanyl

The third wave is the deadliest, and it is the one the country is living in now. The illicit supply is dominated by illicitly manufactured fentanyl, a synthetic opioid roughly 50 to 100 times more potent than morphine. It is mixed into heroin, pressed into counterfeit pills made to look like real pharmacy tablets, and increasingly cut with adulterants like xylazine. The result is that most people who think they are buying heroin or a prescription pill are actually taking fentanyl, often without knowing it. The dose that kills is tiny, and overdose can happen within minutes.

From Pills to Fentanyl in Three Steps

Wave one was prescription painkillers. Wave two was heroin. Wave three is illicitly manufactured fentanyl, 50 to 100 times more potent than morphine and now the dominant street opioid. Each wave proved deadlier than the last. Someone who started with a doctor’s prescription can end up facing the single most dangerous drug environment the country has ever seen.

Prescription opioid numbers cannot be read in isolation, because the pills are one link in a longer chain. The same person counted in the prescription-misuse statistics one year can become a fentanyl statistic the next, which is why the pill data and the overdose data describe a single, connected crisis.

What Prescription Opioids Cost in Lives

What an overdose death countsWhen a death is attributed to opioids, it means an opioid was identified as a cause, often alongside other substances rather than acting alone. Reading the figures with that in mind is why naloxone and getting onto treatment matter no matter which drug is named.

The mortality figures are where the scale becomes impossible to ignore.

In 2024, opioid use disorder and opioid overdose caused 53,774 deaths in the United States, a number that has roughly doubled over the last twenty years[1]. Overdose is the specific event that kills, and it is the reason naloxone, the overdose-reversal drug sold as Narcan, belongs in any home where opioids are used. Community programs that put naloxone into the hands of people who use drugs and those around them measurably reduce overdose deaths[8], and in those programs survival after naloxone is given reaches 98.3%[8].

The Death Toll, in Perspective

53,774 people died from opioid use disorder and overdose in the US in 2024, roughly double the toll of twenty years earlier[1]. That is a packed arena, every single year. Behind each number is a parent, a child, a coworker, a friend.

One of the most dangerous moments comes after a break in use, such as leaving jail, finishing a program, or completing detox. Tolerance drops fast, and returning to a former dose can be fatal. Surviving one overdose is a warning rather than an all-clear: among people who live through a nonfatal overdose, 19.6% had another overdose within a year[9]. Those who start methadone or buprenorphine afterward cut their risk of a repeat overdose by 70%[9].

The cost in lives Figure Source
US opioid overdose deaths, 2024 53,774 [1]
Change over the prior twenty years Roughly doubled [1]
Survival after naloxone in distribution programs 98.3% [8]
Repeat overdose within one year of surviving one 19.6% [9]
Drop in repeat-overdose risk on medication 70% [9]

The deaths are concentrated in moments and gaps we already know how to close, the period right after a break in use, and the window right after a survived overdose. Naloxone on hand and medication started early are the two interventions the data point to again and again.

The Treatment Gap Is the Crisis Within the Crisis

The hardest statistic to sit with is not about how many people are sick. It is about how few are getting the care that works.

Effective, FDA-approved treatments exist, and they save lives. Yet in 2022, only 25.1% of people with opioid use disorder received methadone or buprenorphine, the two most effective medications[1]. That gap is the central failure of the response, because these medications are not a lateral move from one drug to another. Compared with no medication, treatment with methadone or buprenorphine is associated with roughly half the risk of death[1], and opioid agonist therapy carries about a 50% reduction in mortality[10].

Three Out of Four Are Not on the Medication That Works

Only 25.1% of people with opioid use disorder received methadone or buprenorphine in 2022, even though those medications are tied to roughly half the risk of death[1]. The biggest opportunity to save lives is not a new drug. It is closing the gap to the ones that already work.

Time in treatment matters too. Each additional month on buprenorphine is associated with a 25% drop in the odds of using non-prescribed opioids, and each month on methadone with a 17% drop[11]. High adherence pays off in fewer hospital stays: people who took their medication on at least 80% of days had significantly lower use of inpatient and acute care[12]. By contrast, detox on its own, without medication to follow, does not lower overdose risk the way ongoing treatment does[13].

The treatment gap, in evidence Figure Source
People with OUD on methadone or buprenorphine (2022) 25.1% [1]
Reduction in death risk on medication ~50% [1]
Mortality reduction with opioid agonist therapy ~50% [10]
Drop in non-prescribed opioid use per month on buprenorphine 25% [11]
Drop per month on methadone 17% [11]
MOUD in the 6 months after a Medicaid overdose 26% [14]

The lesson in the data is consistent and hopeful. The way out is not white-knuckling through withdrawal, it is getting onto medication and staying there, and every extra month of treatment independently lowers the odds of returning to use.

Did you know?

Starting medication cuts the risk of dying roughly in half, yet three out of four people with opioid use disorder are not on it. In 2022 only 25.1% of people with the disorder received methadone or buprenorphine, even though treatment is associated with about a 50% reduction in mortality compared with no medication[1]. The single biggest opportunity to save lives is closing the gap to the treatments that already work.

Recovery Is Real, and the Data Backs It Up

These numbers describe a heavy problem, but they also describe hundreds of thousands of people who got their lives back.

An 18-month study of nearly 2,000 patients in treatment found that staying in care was associated with abstinence rising from 55% to 77%, alongside fewer overdoses, fewer emergency-department visits, and fewer arrests[15]. Recovery is usually a long-term process rather than a single event, closer to managing diabetes or high blood pressure than flipping a switch. But it works, and it is available now.

Did you know?

Among nearly 2,000 patients followed for 18 months, sustained treatment was associated with abstinence climbing from 55% to 77%, along with fewer overdoses, fewer ER visits, and fewer arrests[15]. The longer people stayed in care, the better they did. Recovery is not a coin flip, it is a path with a known direction.

The most striking statistic here is not the death toll, it is the treatment gap, because it means most of the dying is happening among people who never got the medication that cuts the risk of death roughly in half. The fix is not undiscovered. It is underused.

The Key Prescription Opioid Statistics in One Place

The figures that matter most, gathered together with their sources, so you can see the whole shape of the problem at once.

Statistic Figure Source
US adults with opioid use disorder (2022) 9.37 million (3.7%) [1]
People who misuse opioids who develop addiction 8 to 12% [2]
US opioid overdose deaths (2024) 53,774 [1]
People with OUD on methadone or buprenorphine 25.1% [1]
Reduction in death risk on medication ~50% [1]
People with OUD who have another substance use disorder 59.5% [4]
People affected worldwide ~27 million [3]

What These Prescription Opioid Statistics Mean

Numbers this large can feel abstract, but they describe ordinary people, and they carry two clear messages.

The first is that prescription opioid addiction is common, not shameful. If your use is somewhere in these figures, you are in very large company, and that is a reason to ask for help openly rather than hide. Many people who became addicted started with a prescription written for real pain.

The second is that this is treatable, and the path out is easier than the fear makes it look. Most of the dying is happening among the three out of four people who never got the medication that halves the risk of death. Withdrawal does not have to be faced alone, and detox followed by medication is the safe, proven route. If you are not sure where your use falls, learning the warning signs of prescription opioid addiction is a practical first step. It can also help to see how specific painkillers like oxycodone, hydrocodone, and fentanyl fit the same pattern.

If you use opioids daily, you do not have to quit cold turkey on your own. A supervised medical detox is the safe, easier way, and medications like buprenorphine and methadone make withdrawal far more bearable while cutting the risk of dying.

If any of this lands, the next step doesn’t have to be a big one. Our treatment centers directory can point you to the right level of care. Reaching out today is a real step forward — and one you can make right now.

Frequently asked questions

How many people are addicted to prescription opioids?

In 2022, an estimated 9.37 million US adults, about 3.7% of all adults, met the criteria for an opioid use disorder, a category that covers prescription painkillers along with heroin and fentanyl[1]. Worldwide, roughly 27 million people are affected[3]. Most people prescribed opioids never become addicted, but the minority who do number in the millions.

What percentage of people who misuse opioids become addicted?

Roughly 8 to 12% of people who misuse opioids go on to develop an opioid use disorder[2]. Misuse, meaning taking a pill more often than prescribed, using someone else’s medication, or taking it to get high, is more common than addiction itself. Addiction is the smaller, more serious circle inside it, marked by craving and loss of control.

How many people die from opioids each year?

Opioid use disorder and opioid overdose caused 53,774 deaths in the United States in 2024, a number that has roughly doubled over the past twenty years[1]. Overdose is the event that kills, and it can be reversed with naloxone (Narcan) if someone acts fast. The risk is highest after a break in use, such as leaving jail or finishing detox, when tolerance has dropped.

Do prescription painkillers really lead to heroin and fentanyl?

For many people, yes. A large share of today’s heroin and illicit-fentanyl users first encountered opioids through prescription painkillers, then moved to cheaper street drugs when pills became hard to get. That street supply is now dominated by illicitly manufactured fentanyl, which is roughly 50 to 100 times more potent than morphine and accounts for the steep rise in overdose deaths. It is a documented pathway, which is why prescription and overdose statistics describe one connected crisis.

What else do people with opioid addiction usually struggle with?

Opioid use disorder rarely travels alone. Among people with it, 59.5% also have another current substance use disorder[4], 36.1% have depression, 29.1% have anxiety, and 18.1% have PTSD[5], and about 45.3% of those in opioid-substitution treatment also live with chronic pain[6]. Good treatment expects this complexity and treats the whole person, which is part of why it works.

Is prescription opioid addiction treatable?

Yes, and the treatments work well. Starting methadone or buprenorphine is associated with roughly half the risk of death compared with no medication[1], and each additional month in treatment further lowers the odds of using non-prescribed opioids[11]. Recovery is real: in an 18-month study, sustained treatment was tied to abstinence rising from 55% to 77%[15]. The problem is access, not effectiveness: in 2022 only 25.1% of people with the disorder received these medications[1].

What is the safest way to stop taking prescription opioids?

Not cold turkey on your own. A supervised medical detox is the safe route, and medications like buprenorphine and methadone make withdrawal far more bearable while cutting the risk of dying. Detox without medication to follow does not lower overdose risk the way ongoing treatment does[13], so the goal is to get onto medication and stay there. Free, confidential help is available 24/7 from SAMHSA at 1-800-662-HELP (4357).

Get Treatment Help

If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.

Exclusive offer: 20% Off BetterHelp*

Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

15 Sources
  1. Harris, Miriam T H, Weinstein, Zoe M, Walley, Alexander Y (2026). Medications for Opioid Use Disorder, Opioid Withdrawal, and Opioid Overdose: A Review. JAMA. https://doi.org/10.1001/jama.2025.26348
  2. Courchesne-Krak, Natasia S, Chandrasekaran, Anirudh R, Gonzalez, Jean, Bianchi, Sevim B, Tran, Vinh, Johnson, Eric O, Troiani, Vanessa, Hettema, John M, Stein, Murray B, Coon, Hilary, Docherty, Anna R, Berretini, Wade H, MacKillop, James, de Wit, Harriet, Marienfeld, Carla, Palmer, Abraham A, Sanchez-Roige, Sandra (2025). Prescription Opioid Medication Survey: A Tool to Collect Deep Phenotypic Data on the Multifactorial Pathways to Opioid Use Disorder in Clinical and Population-Based Cohorts. Complex psychiatry. https://doi.org/10.1159/000546389
  3. Edinoff, Amber N, Sall, Saveen, Honore, Lauryn G, Dies, Ross M, Zaheri, Alexa R, Kataria, Saurabh, Jackson, Eric D, Shekoohi, Sahar, Cornett, Elyse M, Murnane, Kevin S, Kaye, Adam M, Kaye, Alan D (2023). The Use of Oxytocin for the Treatment of Opioid Use Disorder. Current pain and headache reports. https://doi.org/10.1007/s11916-023-01105-6
  4. Santo, Thomas, Gisev, Natasa, Campbell, Gabrielle, Colledge-Frisby, Samantha, Wilson, Jack, Tran, Lucy Thi, Lynch, Michelle, Martino-Burke, Daniel, Taylor, Sophia, Degenhardt, Louisa (2024). Prevalence of comorbid substance use disorders among people with opioid use disorder: A systematic review & meta-analysis. The International journal on drug policy. https://doi.org/10.1016/j.drugpo.2024.104434
  5. Santo, Thomas, Campbell, Gabrielle, Gisev, Natasa, Martino-Burke, Daniel, Wilson, Jack, Colledge-Frisby, Samantha, Clark, Brodie, Tran, Lucy Thi, Degenhardt, Louisa (2022). Prevalence of mental disorders among people with opioid use disorder: A systematic review and meta-analysis. Drug and alcohol dependence. https://doi.org/10.1016/j.drugalcdep.2022.109551
  6. Delorme, Jessica, Kerckhove, Nicolas, Authier, Nicolas, Pereira, Bruno, Bertin, Célian, Chenaf, Chouki (2023). Systematic Review and Meta-Analysis of the Prevalence of Chronic Pain Among Patients With Opioid Use Disorder and Receiving Opioid Substitution Therapy. The journal of pain. https://doi.org/10.1016/j.jpain.2022.08.008
  7. Regmi, Sanjaya, Kedia, Satish K, Ahuja, Nikhil A, Lee, Guijin, Entwistle, Coree, Dillon, Patrick J (2024). Association Between Adverse Childhood Experiences and Opioid Use-Related Behaviors: A Systematic Review. Trauma, violence & abuse. https://doi.org/10.1177/15248380231205821
  8. Fischer, Leah S, Asher, Alice, Stein, Renee, Becasen, Jeffrey, Doreson, Amanda, Mermin, Jonathan, Meltzer, Martin I, Edlin, Brian R (2025). Effectiveness of naloxone distribution in community settings to reduce opioid overdose deaths among people who use drugs: a systematic review and meta-analysis. BMC public health. https://doi.org/10.1186/s12889-025-22210-8
  9. Crystal, Stephen, Nowels, Molly, Samples, Hillary, Olfson, Mark, Williams, Arthur Robin, Treitler, Peter (2022). Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients. Drug and alcohol dependence. https://doi.org/10.1016/j.drugalcdep.2022.109269
  10. Perry, Danielle, Kirkwood, Jessica Em, Doroshuk, Marissa L, Kelmer, Michael, Korownyk, Christina S, Ton, Joey, Garrison, Scott R (2025). Opioid agonist therapy for opioid use disorder in primary versus specialty care. The Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd013672.pub2
  11. Jiang, Xinyi, Guy, Gery P, Dever, Jill A, Richardson, John S, Dunlap, Laura J, Turcios, Didier, Wolicki, Sara Beth, Edlund, Mark J, Losby, Jan L (2025). Association Between Length of Buprenorphine or Methadone Use and Nonprescribed Opioid Use Among Individuals with Opioid Use Disorder: A Cohort Study. Substance use & addiction journal. https://doi.org/10.1177/29767342241266038
  12. Gopaldas, Manesh, Wenzel, Kevin, Campbell, Aimee N C, Jalali, Ali, Fishman, Marc, Rotrosen, John, Nunes, Edward V, Murphy, Sean M (2023). Impact of Medication-Based Treatment on Health Care Utilization Among Individuals With Opioid Use Disorder. Psychiatric services (Washington, D.C.). https://doi.org/10.1176/appi.ps.20220549
  13. Wakeman, Sarah E, Larochelle, Marc R, Ameli, Omid, Chaisson, Christine E, McPheeters, Jeffrey Thomas, Crown, William H, Azocar, Francisca, Sanghavi, Darshak M (2020). Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder. JAMA network open. https://doi.org/10.1001/jamanetworkopen.2019.20622
  14. Samples, Hillary, Cook, Sharon, Hua, Jialiang, Treitler, Peter, Stone, Elizabeth M, Miles, Jennifer, Olfson, Mark, Crystal, Stephen (2026). Timely Receipt of New Medication Treatment After Acute Care Encounters for Opioid Overdose in the U.S. Medicaid Population. Journal of general internal medicine. https://doi.org/10.1007/s11606-025-10108-5
  15. Dever, Jill A, Hertz, Marci F, Dunlap, Laura J, Richardson, John S, Wolicki, Sara Beth, Biggers, Bradley B, Edlund, Mark J, Bohm, Michele K, Turcios, Didier, Jiang, Xinyi, Zhou, Hong, Evans, Mary E, Guy, Gery P (2024). The Medications for Opioid Use Disorder Study: Methods and Initial Outcomes From an 18-Month Study of Patients in Treatment for Opioid Use Disorder. Public health reports (Washington, D.C. : 1974). https://doi.org/10.1177/00333549231222479
Written by
Jessica Miller is the Content Manager of Addiction Help

Editorial Director

Jessica Miller is the Editorial Director of Addiction Help. Jessica graduated from the University of South Florida (USF) with an English degree and combines her writing expertise and passion for helping others to deliver reliable information to those impacted by addiction. Informed by her personal journey to recovery and support of loved ones in sobriety, Jessica's empathetic and authentic approach resonates deeply with the Addiction Help community.

Reviewed by
  • Fact-Checked
  • Editor
Kent S. Hoffman, D.O. is a founder of Addiction Help

Co-Founder & Chief Medical Officer

Kent S. Hoffman, D.O. has been an expert in addiction medicine for more than 15 years. In addition to managing a successful family medical practice, Dr. Hoffman is board certified in addiction medicine by the American Osteopathic Academy of Addiction Medicine (AOAAM). Dr. Hoffman has successfully treated hundreds of patients battling addiction. Dr. Hoffman is the Co-Founder and Chief Medical Officer of AddictionHelp.com and ensures the website’s medical content and messaging quality.

Real Help. Real Recovery.

Compare centers, explore options and start your path to recovery today.

Find Treatment Now

"AddictionHelp.com is helping to make recovery available to EVERYONE!"

- Angela N.